Global Postmenopausal Vaginal Atrophy Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4947478
- 103 Pages
- April 2022
- Medical Devices
The United States Postmenopausal Vaginal Atrophy Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Postmenopausal Vaginal Atrophy Therapeutics market, reaching US$ million by the year 2028. As for the Europe Postmenopausal Vaginal Atrophy Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Postmenopausal Vaginal Atrophy Therapeutics players cover Endoceutics, Accord Healthcare, Pfizer, and Novo Nordisk, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Postmenopausal Vaginal Atrophy Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Estrogen-based Drugs
Non-estrogen-based Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Specialist Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Endoceutics
Accord Healthcare
Pfizer
Novo Nordisk
Teva Pharmaceuticals
Shionogi
Bionovo
QuatRx Pharmaceutical Company
Bayer AG
TherapeuticsMD
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Postmenopausal Vaginal Atrophy Therapeutics Market Size 2017-2028
2.1.2 Postmenopausal Vaginal Atrophy Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Postmenopausal Vaginal Atrophy Therapeutics Segment by Type
2.2.1 Estrogen-based Drugs
2.2.2 Non-estrogen-based Drugs
2.3 Postmenopausal Vaginal Atrophy Therapeutics Market Size by Type
2.3.1 Postmenopausal Vaginal Atrophy Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Postmenopausal Vaginal Atrophy Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Specialist Clinic
2.5 Postmenopausal Vaginal Atrophy Therapeutics Market Size by Application
2.5.1 Postmenopausal Vaginal Atrophy Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application (2017-2022)
3 Postmenopausal Vaginal Atrophy Therapeutics Market Size by Player
3.1 Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Players
3.1.1 Global Postmenopausal Vaginal Atrophy Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Postmenopausal Vaginal Atrophy Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Postmenopausal Vaginal Atrophy Therapeutics by Regions
4.1 Postmenopausal Vaginal Atrophy Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth (2017-2022)
4.3 APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth (2017-2022)
4.4 Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size by Country (2017-2022)
5.2 Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size by Type (2017-2022)
5.3 Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size by Region (2017-2022)
6.2 APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size by Type (2017-2022)
6.3 APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Postmenopausal Vaginal Atrophy Therapeutics by Country (2017-2022)
7.2 Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size by Type (2017-2022)
7.3 Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.1 Global Postmenopausal Vaginal Atrophy Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Postmenopausal Vaginal Atrophy Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Postmenopausal Vaginal Atrophy Therapeutics Forecast
10.1.3 APAC Postmenopausal Vaginal Atrophy Therapeutics Forecast
10.1.4 Europe Postmenopausal Vaginal Atrophy Therapeutics Forecast
10.1.5 Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Forecast
10.2 Americas Postmenopausal Vaginal Atrophy Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.2.2 Canada Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.2.3 Mexico Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.2.4 Brazil Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.3 APAC Postmenopausal Vaginal Atrophy Therapeutics Forecast by Region (2023-2028)
10.3.1 China Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.3.2 Japan Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.3.3 Korea Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.3.4 Southeast Asia Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.3.5 India Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.3.6 Australia Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.4 Europe Postmenopausal Vaginal Atrophy Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.4.2 France Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.4.3 UK Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.4.4 Italy Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.4.5 Russia Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.5 Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.5.2 South Africa Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.5.3 Israel Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.5.4 Turkey Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.5.5 GCC Countries Postmenopausal Vaginal Atrophy Therapeutics Market Forecast
10.6 Global Postmenopausal Vaginal Atrophy Therapeutics Forecast by Type (2023-2028)
10.7 Global Postmenopausal Vaginal Atrophy Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Endoceutics
11.1.1 Endoceutics Company Information
11.1.2 Endoceutics Postmenopausal Vaginal Atrophy Therapeutics Product Offered
11.1.3 Endoceutics Postmenopausal Vaginal Atrophy Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Endoceutics Main Business Overview
11.1.5 Endoceutics Latest Developments
11.2 Accord Healthcare
11.2.1 Accord Healthcare Company Information
11.2.2 Accord Healthcare Postmenopausal Vaginal Atrophy Therapeutics Product Offered
11.2.3 Accord Healthcare Postmenopausal Vaginal Atrophy Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Accord Healthcare Main Business Overview
11.2.5 Accord Healthcare Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Postmenopausal Vaginal Atrophy Therapeutics Product Offered
11.3.3 Pfizer Postmenopausal Vaginal Atrophy Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Postmenopausal Vaginal Atrophy Therapeutics Product Offered
11.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novo Nordisk Main Business Overview
11.4.5 Novo Nordisk Latest Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Information
11.5.2 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy Therapeutics Product Offered
11.5.3 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Teva Pharmaceuticals Main Business Overview
11.5.5 Teva Pharmaceuticals Latest Developments
11.6 Shionogi
11.6.1 Shionogi Company Information
11.6.2 Shionogi Postmenopausal Vaginal Atrophy Therapeutics Product Offered
11.6.3 Shionogi Postmenopausal Vaginal Atrophy Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Shionogi Main Business Overview
11.6.5 Shionogi Latest Developments
11.7 Bionovo
11.7.1 Bionovo Company Information
11.7.2 Bionovo Postmenopausal Vaginal Atrophy Therapeutics Product Offered
11.7.3 Bionovo Postmenopausal Vaginal Atrophy Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bionovo Main Business Overview
11.7.5 Bionovo Latest Developments
11.8 QuatRx Pharmaceutical Company
11.8.1 QuatRx Pharmaceutical Company Company Information
11.8.2 QuatRx Pharmaceutical Company Postmenopausal Vaginal Atrophy Therapeutics Product Offered
11.8.3 QuatRx Pharmaceutical Company Postmenopausal Vaginal Atrophy Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 QuatRx Pharmaceutical Company Main Business Overview
11.8.5 QuatRx Pharmaceutical Company Latest Developments
11.9 Bayer AG
11.9.1 Bayer AG Company Information
11.9.2 Bayer AG Postmenopausal Vaginal Atrophy Therapeutics Product Offered
11.9.3 Bayer AG Postmenopausal Vaginal Atrophy Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bayer AG Main Business Overview
11.9.5 Bayer AG Latest Developments
11.10 TherapeuticsMD
11.10.1 TherapeuticsMD Company Information
11.10.2 TherapeuticsMD Postmenopausal Vaginal Atrophy Therapeutics Product Offered
11.10.3 TherapeuticsMD Postmenopausal Vaginal Atrophy Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 TherapeuticsMD Main Business Overview
11.10.5 TherapeuticsMD Latest Developments
12 Research Findings and Conclusion
Table 1. Postmenopausal Vaginal Atrophy Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Estrogen-based Drugs
Table 3. Major Players of Non-estrogen-based Drugs
Table 4. Postmenopausal Vaginal Atrophy Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Type (2017-2022)
Table 7. Postmenopausal Vaginal Atrophy Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application (2017-2022)
Table 10. Global Postmenopausal Vaginal Atrophy Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share by Player (2020-2022)
Table 12. Postmenopausal Vaginal Atrophy Therapeutics Key Players Head office and Products Offered
Table 13. Postmenopausal Vaginal Atrophy Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Country (2017-2022)
Table 20. Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Type (2017-2022)
Table 22. Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application (2017-2022)
Table 24. APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Region (2017-2022)
Table 26. APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Type (2017-2022)
Table 28. APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application (2017-2022)
Table 30. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Country (2017-2022)
Table 32. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Type (2017-2022)
Table 34. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Postmenopausal Vaginal Atrophy Therapeutics
Table 43. Key Market Challenges & Risks of Postmenopausal Vaginal Atrophy Therapeutics
Table 44. Key Industry Trends of Postmenopausal Vaginal Atrophy Therapeutics
Table 45. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Endoceutics Details, Company Type, Postmenopausal Vaginal Atrophy Therapeutics Area Served and Its Competitors
Table 52. Endoceutics Postmenopausal Vaginal Atrophy Therapeutics Product Offered
Table 53. Endoceutics Postmenopausal Vaginal Atrophy Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Endoceutics Main Business
Table 55. Endoceutics Latest Developments
Table 56. Accord Healthcare Details, Company Type, Postmenopausal Vaginal Atrophy Therapeutics Area Served and Its Competitors
Table 57. Accord Healthcare Postmenopausal Vaginal Atrophy Therapeutics Product Offered
Table 58. Accord Healthcare Main Business
Table 59. Accord Healthcare Postmenopausal Vaginal Atrophy Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Accord Healthcare Latest Developments
Table 61. Pfizer Details, Company Type, Postmenopausal Vaginal Atrophy Therapeutics Area Served and Its Competitors
Table 62. Pfizer Postmenopausal Vaginal Atrophy Therapeutics Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Postmenopausal Vaginal Atrophy Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Pfizer Latest Developments
Table 66. Novo Nordisk Details, Company Type, Postmenopausal Vaginal Atrophy Therapeutics Area Served and Its Competitors
Table 67. Novo Nordisk Postmenopausal Vaginal Atrophy Therapeutics Product Offered
Table 68. Novo Nordisk Main Business
Table 69. Novo Nordisk Postmenopausal Vaginal Atrophy Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Novo Nordisk Latest Developments
Table 71. Teva Pharmaceuticals Details, Company Type, Postmenopausal Vaginal Atrophy Therapeutics Area Served and Its Competitors
Table 72. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy Therapeutics Product Offered
Table 73. Teva Pharmaceuticals Main Business
Table 74. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Teva Pharmaceuticals Latest Developments
Table 76. Shionogi Details, Company Type, Postmenopausal Vaginal Atrophy Therapeutics Area Served and Its Competitors
Table 77. Shionogi Postmenopausal Vaginal Atrophy Therapeutics Product Offered
Table 78. Shionogi Main Business
Table 79. Shionogi Postmenopausal Vaginal Atrophy Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Shionogi Latest Developments
Table 81. Bionovo Details, Company Type, Postmenopausal Vaginal Atrophy Therapeutics Area Served and Its Competitors
Table 82. Bionovo Postmenopausal Vaginal Atrophy Therapeutics Product Offered
Table 83. Bionovo Main Business
Table 84. Bionovo Postmenopausal Vaginal Atrophy Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Bionovo Latest Developments
Table 86. QuatRx Pharmaceutical Company Details, Company Type, Postmenopausal Vaginal Atrophy Therapeutics Area Served and Its Competitors
Table 87. QuatRx Pharmaceutical Company Postmenopausal Vaginal Atrophy Therapeutics Product Offered
Table 88. QuatRx Pharmaceutical Company Main Business
Table 89. QuatRx Pharmaceutical Company Postmenopausal Vaginal Atrophy Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. QuatRx Pharmaceutical Company Latest Developments
Table 91. Bayer AG Details, Company Type, Postmenopausal Vaginal Atrophy Therapeutics Area Served and Its Competitors
Table 92. Bayer AG Postmenopausal Vaginal Atrophy Therapeutics Product Offered
Table 93. Bayer AG Main Business
Table 94. Bayer AG Postmenopausal Vaginal Atrophy Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Bayer AG Latest Developments
Table 96. TherapeuticsMD Details, Company Type, Postmenopausal Vaginal Atrophy Therapeutics Area Served and Its Competitors
Table 97. TherapeuticsMD Postmenopausal Vaginal Atrophy Therapeutics Product Offered
Table 98. TherapeuticsMD Main Business
Table 99. TherapeuticsMD Postmenopausal Vaginal Atrophy Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. TherapeuticsMD Latest Developments
List of Figures
Figure 1. Postmenopausal Vaginal Atrophy Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Type in 2021
Figure 7. Postmenopausal Vaginal Atrophy Therapeutics in Hospital
Figure 8. Global Postmenopausal Vaginal Atrophy Therapeutics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Postmenopausal Vaginal Atrophy Therapeutics in Specialist Clinic
Figure 10. Global Postmenopausal Vaginal Atrophy Therapeutics Market: Specialist Clinic (2017-2022) & ($ Millions)
Figure 11. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application in 2021
Figure 12. Global Postmenopausal Vaginal Atrophy Therapeutics Revenue Market Share by Player in 2021
Figure 13. Global Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size 2017-2022 ($ Millions)
Figure 15. APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size 2017-2022 ($ Millions)
Figure 16. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Americas Postmenopausal Vaginal Atrophy Therapeutics Value Market Share by Country in 2021
Figure 19. Americas Postmenopausal Vaginal Atrophy Therapeutics Consumption Market Share by Type in 2021
Figure 20. Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application in 2021
Figure 21. United States Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Region in 2021
Figure 26. APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application in 2021
Figure 27. China Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Country in 2021
Figure 34. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Type in 2021
Figure 35. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application in 2021
Figure 36. Germany Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size Market Share by Application in 2021
Figure 44. Egypt Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Postmenopausal Vaginal Atrophy Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 50. APAC Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 51. Europe Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. United States Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Canada Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. China Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Japan Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Korea Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. India Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Australia Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Germany Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. France Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. UK Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Italy Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Russia Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Spain Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Israel Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Postmenopausal Vaginal Atrophy Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
